A prescription pill derived from fish-oil pill received the regulatory nod Friday to expand its use as a supplementary treatment, alongside statins, to more patients at risk of heart attack or stroke.

The FDA approved the Amarin Pharma drug, icosapent ethyl (Vascepa), for use as a secondary treatment for adults who are taking statins and have elevated levels of triglycerides, a type of fat in the blood. Those patients must also have established heart disease or diabetes, and two or more additional heart disease risk factors.

High levels of triglycerides can contribute to an increased risk of heart attack or stroke… Read more »